Gemstone Biotherapeutics

United States
Rosedale, Indiana, United States, 21211

Company profile

Gemstone Biotherapeutics company profile

Gemstone Biotherapeutics is a pre-clinical research and development initiative based in Baltimore, Maryland. Gemstone is dedicated to the field of regenerative medicine and specializes in developing improved methods for advanced wound healing and tissue vascularization using licensed technology from Johns Hopkins University. Their core technologies include innovative polymeric hydrogels and stem cell engineering methodologies.

Business identity

Contact email
[email protected]
Phone number
(443) 873-7010
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2013-01-01, Year

Headquarters

Postal code
21211
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
4
Total equity funding
$2.6M
Last funding
Series Unknown / $250,000 / 2019-08-28
Last equity funding
Series Unknown / $250,000
Investors
3
Lead investors
3
Founders
1
Articles
1

Founders and investors

Founders

George Davis

Lead investors

Gamma3National Science FoundationUniversity System of Maryland Momentum Fund

Investors

Gamma3National Science FoundationUniversity System of Maryland Momentum Fund